Medikit Co (7749.T) Stock Price

Medikit Co Price

CLOSED
2,861.00JPY-7.00 (-0.24 %)
Market closed

Over the last 19 years Medikit Co grew revenue by 3.8% annually, reaching 22.55 B JPY. Earnings per share have declined at 0.2% per year over the last 19 years. For Medikit Co, the net margin of 13.4% is broadly stable versus 13.8% a few years ago. At today's price the dividend yield works out to roughly 3.32%. The payout ratio is around 46% of earnings. The stock trades about 13% above its 52-week low.

Medikit Co stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Medikit Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Medikit Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Medikit Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Medikit Co Stock Price History
DateMedikit Co Price
8/21/20262,861.00 JPY
8/20/20262,868.00 JPY
8/19/20262,827.00 JPY
8/18/20262,849.00 JPY
8/17/20262,843.00 JPY
8/14/20262,860.00 JPY
8/13/20262,831.00 JPY
8/12/20262,821.00 JPY
8/10/20262,849.00 JPY
8/7/20262,827.00 JPY
8/6/20262,803.00 JPY
8/5/20262,801.00 JPY
8/4/20262,806.00 JPY
8/3/20262,807.00 JPY
7/31/20262,820.00 JPY
7/30/20262,803.00 JPY
7/29/20262,805.00 JPY
7/28/20262,803.00 JPY
7/27/20262,812.00 JPY
7/24/20262,800.00 JPY
7/23/20262,800.00 JPY
7/22/20262,805.00 JPY
7/21/20262,802.00 JPY
7/17/20262,778.00 JPY
7/16/20262,785.00 JPY
7/15/20262,809.00 JPY
7/14/20262,783.00 JPY
7/13/20262,819.00 JPY
7/10/20262,823.00 JPY
7/9/20262,813.00 JPY
7/8/20262,813.00 JPY
7/7/20262,810.00 JPY
7/6/20262,796.00 JPY
7/3/20262,792.00 JPY
7/2/20262,780.00 JPY
7/1/20262,817.00 JPY
6/30/20262,788.00 JPY
6/29/20262,800.00 JPY
6/26/20262,805.00 JPY
6/25/20262,810.00 JPY
6/24/20262,787.00 JPY
6/23/20262,788.00 JPY
6/22/20262,788.00 JPY
6/19/20262,796.00 JPY
6/18/20262,806.00 JPY
6/17/20262,821.00 JPY
6/16/20262,808.00 JPY
6/15/20262,840.00 JPY
6/12/20262,900.00 JPY
6/11/20262,816.00 JPY
6/10/20262,786.00 JPY
6/9/20262,784.00 JPY
6/8/20262,807.00 JPY
6/5/20262,852.00 JPY
6/4/20262,795.00 JPY
6/3/20262,770.00 JPY
6/2/20262,806.00 JPY
6/1/20262,850.00 JPY
5/29/20262,864.00 JPY
5/28/20262,873.00 JPY
5/27/20262,875.00 JPY
5/26/20262,901.00 JPY
5/25/20262,901.00 JPY
5/22/20262,930.00 JPY
5/21/20262,960.00 JPY
5/20/20262,956.00 JPY
5/19/20262,969.00 JPY
5/18/20262,956.00 JPY
5/15/20262,971.00 JPY
5/14/20263,000.00 JPY
5/13/20262,996.00 JPY
5/12/20262,980.00 JPY
5/11/20262,976.00 JPY
5/8/20262,975.00 JPY
5/7/20262,975.00 JPY
5/1/20262,960.00 JPY
4/30/20262,973.00 JPY
4/28/20262,970.00 JPY
4/27/20262,966.00 JPY
4/24/20262,958.00 JPY
4/23/20262,985.00 JPY
4/22/20262,985.00 JPY
4/21/20262,972.00 JPY
4/20/20262,970.00 JPY
4/17/20262,976.00 JPY
4/16/20262,972.00 JPY
4/15/20262,960.00 JPY
4/14/20262,960.00 JPY
4/13/20262,967.00 JPY
4/10/20262,981.00 JPY
4/9/20262,993.00 JPY
4/8/20262,993.00 JPY
4/7/20262,994.00 JPY
4/6/20262,994.00 JPY
4/3/20262,997.00 JPY
3/27/20263,005.00 JPY
3/26/20263,030.00 JPY
3/25/20262,988.00 JPY
3/24/20262,967.00 JPY
3/23/20262,984.00 JPY
3/19/20262,980.00 JPY
3/18/20262,985.00 JPY
3/17/20262,970.00 JPY
3/16/20262,979.00 JPY
3/13/20262,972.00 JPY
3/12/20262,978.00 JPY
3/11/20262,987.00 JPY
3/9/20262,995.00 JPY
3/6/20263,010.00 JPY
3/5/20262,997.00 JPY
2/26/20263,000.00 JPY
2/25/20262,987.00 JPY
2/24/20262,994.00 JPY
2/20/20262,983.00 JPY
2/19/20262,980.00 JPY
2/18/20262,997.00 JPY
2/17/20262,987.00 JPY
2/16/20262,993.00 JPY
2/13/20263,000.00 JPY
2/12/20263,030.00 JPY
2/10/20263,025.00 JPY
2/9/20263,005.00 JPY
2/6/20262,989.00 JPY
2/5/20263,010.00 JPY
2/4/20263,030.00 JPY
2/3/20263,000.00 JPY
2/2/20262,991.00 JPY
1/30/20262,986.00 JPY
1/29/20262,987.00 JPY
1/28/20262,981.00 JPY
1/27/20262,995.00 JPY
1/26/20263,005.00 JPY
1/23/20262,983.00 JPY
1/22/20262,950.00 JPY
1/21/20262,910.00 JPY
1/20/20262,924.00 JPY
1/19/20262,978.00 JPY
1/16/20262,985.00 JPY
1/15/20262,998.00 JPY
1/14/20263,010.00 JPY
1/13/20262,988.00 JPY
1/9/20263,040.00 JPY
1/8/20262,999.00 JPY
1/7/20262,964.00 JPY
1/6/20262,987.00 JPY
1/5/20262,965.00 JPY
12/30/20253,025.00 JPY
12/29/20253,005.00 JPY
12/26/20252,971.00 JPY
12/25/20253,010.00 JPY
12/24/20252,997.00 JPY
12/23/20252,960.00 JPY
12/22/20252,906.00 JPY
12/19/20252,870.00 JPY
12/18/20252,929.00 JPY
12/17/20252,852.00 JPY
12/16/20252,841.00 JPY
12/15/20252,810.00 JPY
12/12/20252,812.00 JPY
12/11/20252,835.00 JPY
12/10/20252,831.00 JPY
12/9/20252,847.00 JPY
12/8/20252,820.00 JPY
12/5/20252,819.00 JPY
12/4/20252,820.00 JPY
12/3/20252,791.00 JPY
12/2/20252,832.00 JPY
12/1/20252,807.00 JPY
11/28/20252,893.00 JPY
11/27/20252,935.00 JPY
11/26/20252,881.00 JPY
11/25/20252,889.00 JPY
11/21/20252,779.00 JPY
11/20/20252,742.00 JPY
11/19/20252,754.00 JPY
11/18/20252,745.00 JPY
11/17/20252,759.00 JPY
11/14/20252,752.00 JPY
11/13/20252,729.00 JPY
11/12/20252,732.00 JPY
11/11/20252,731.00 JPY
11/10/20252,763.00 JPY
11/7/20252,760.00 JPY
11/6/20252,751.00 JPY
11/5/20252,745.00 JPY
11/4/20252,751.00 JPY
10/31/20252,709.00 JPY
10/30/20252,705.00 JPY
10/29/20252,716.00 JPY
10/28/20252,713.00 JPY
10/27/20252,745.00 JPY
10/24/20252,732.00 JPY
10/23/20252,707.00 JPY
10/22/20252,694.00 JPY
10/21/20252,667.00 JPY
10/20/20252,670.00 JPY
10/17/20252,637.00 JPY
10/16/20252,632.00 JPY
10/15/20252,628.00 JPY
10/14/20252,642.00 JPY
10/10/20252,677.00 JPY
10/9/20252,678.00 JPY
10/8/20252,712.00 JPY
10/7/20252,694.00 JPY
10/6/20252,716.00 JPY
10/3/20252,709.00 JPY
10/2/20252,705.00 JPY
10/1/20252,723.00 JPY
9/30/20252,765.00 JPY
9/29/20252,749.00 JPY
9/26/20252,754.00 JPY
9/25/20252,727.00 JPY
9/24/20252,735.00 JPY
9/22/20252,741.00 JPY
9/19/20252,726.00 JPY
9/18/20252,745.00 JPY
9/17/20252,750.00 JPY
9/16/20252,741.00 JPY
9/12/20252,729.00 JPY
9/11/20252,720.00 JPY
9/10/20252,729.00 JPY
9/9/20252,707.00 JPY
9/8/20252,737.00 JPY
9/5/20252,751.00 JPY
9/4/20252,788.00 JPY
9/3/20252,820.00 JPY
9/2/20252,813.00 JPY
9/1/20252,736.00 JPY
8/29/20252,531.00 JPY
8/28/20252,530.00 JPY
8/27/20252,539.00 JPY
8/26/20252,525.00 JPY
Access this data via the Eulerpool API
Get Free API Key

Medikit Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
17.45 B JPY
3.63 B JPY
2.47 B JPY
Jan 1, 2019
18.50 B JPY
3.86 B JPY
2.58 B JPY
Jan 1, 2020
19.89 B JPY
4.32 B JPY
2.89 B JPY
Jan 1, 2021
19.31 B JPY
3.78 B JPY
2.66 B JPY
Jan 1, 2022
20.13 B JPY
4.42 B JPY
2.99 B JPY
Jan 1, 2023
21.61 B JPY
4.11 B JPY
2.86 B JPY
Jan 1, 2024
21.85 B JPY
4.67 B JPY
3.07 B JPY
Jan 1, 2025
22.55 B JPY
4.49 B JPY
3.01 B JPY

Medikit Co Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 26, 2026, 6:22 AM
 
REVENUEB JPY
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB JPY
EBITB JPY
EBIT MARGIN%
NET INCOMEB JPY
NET INCOME GROWTH%
DIV.JPY
DIV. GROWTH%
SHARESM
2010201120122013201420152016201720182019202020212022202320242025
12.9713.7814.1313.9914.5314.8515.7216.8517.4518.5019.8919.3120.1321.6121.8522.55
5.176.252.53-0.963.852.215.877.173.536.057.52-2.924.247.341.123.22
45.9847.7247.7844.6444.6943.7943.2642.3942.5041.6241.8239.3140.6438.5040.0538.43
5.966.586.756.256.496.506.807.147.417.708.327.598.188.328.758.67
3.003.553.673.053.143.433.603.513.633.864.323.784.424.114.674.49
23.1025.7425.9621.7721.6323.1222.9020.8220.8320.8421.7319.5521.9519.0421.3919.89
1.762.112.031.831.952.182.312.302.472.582.892.662.992.863.073.01
9.3220.01-3.69-9.996.3412.235.63-0.527.414.5012.07-7.9012.56-4.317.16-1.82
50.0050.0050.0055.0055.0057.0065.0070.0075.0075.0090.00100.00100.0075.0090.0095.00
–––10.00–3.6414.047.697.14–20.0011.11–-25.0020.005.56
9.009.009.009.009.0018.3116.9516.9516.9516.9516.9616.9016.8016.7816.3314.73
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Medikit Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Medikit Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Medikit Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Medikit Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Medikit Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Medikit Co stock margins

The Medikit Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Medikit Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Medikit Co.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
42.50 %
20.83 %
14.13 %
Jan 1, 2019
41.63 %
20.84 %
13.92 %
Jan 1, 2020
41.83 %
21.73 %
14.52 %
Jan 1, 2021
39.31 %
19.55 %
13.77 %
Jan 1, 2022
40.64 %
21.95 %
14.87 %
Jan 1, 2023
38.50 %
19.04 %
13.26 %
Jan 1, 2024
40.06 %
21.39 %
14.05 %
Jan 1, 2025
38.43 %
19.89 %
13.36 %

Medikit Co Stock Revenue, EBIT, Earnings per Share

The Medikit Co earnings per share therefore indicates how much revenue Medikit Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
1,028.97 JPY
214.29 JPY
145.40 JPY
Jan 1, 2019
1,091.29 JPY
227.43 JPY
151.96 JPY
Jan 1, 2020
1,173.27 JPY
254.98 JPY
170.33 JPY
Jan 1, 2021
1,142.96 JPY
223.44 JPY
157.37 JPY
Jan 1, 2022
1,198.18 JPY
263.00 JPY
178.15 JPY
Jan 1, 2023
1,287.37 JPY
245.12 JPY
170.67 JPY
Jan 1, 2024
1,337.98 JPY
286.20 JPY
187.95 JPY
Jan 1, 2025
1,530.88 JPY
304.46 JPY
204.55 JPY

Medikit Co business model & stock analysis

The history of the company Medikit Co Ltd dates back to the 1970s, when the company was founded as a small family business in Japan. Over time, Medikit grew into a multinational company with offices in Asia, Europe, and North America. Medikit's business model is focused on developing, manufacturing, and selling innovative medical devices and consumables. The company specializes in three areas: Medical Instruments, Medical Consumables, and Medical Technology. In the field of Medical Instruments, Medikit offers a wide range of products for use in diagnosis and therapy. These include endoscopes for examining hollow organs such as the stomach and intestines, as well as flexible endoscopes for examining bronchi and lungs. In addition, the range includes ultrasound devices for diagnosing heart, blood vessel, and musculoskeletal disorders, as well as surgical instruments for use in minimally invasive surgery. In the field of Medical Consumables, Medikit offers bandages, injection and infusion sets, catheters and urinary drainage systems, as well as blood collection systems. Products for home care, such as ostomy care and incontinence supplies, are also part of the portfolio. In the field of Medical Technology, Medikit offers technologies for telemedicine and hospital routine. These include systems for wireless transmission of vital parameters such as blood pressure and heart rate, as well as data storage and processing systems for medical examination data. Medikit is constantly striving to improve its products and offer customers the best products. This has resulted in Medikit having one of the best research and development departments in medical technology. Research is conducted, among other things, on better diagnostic procedures and new surgical methods. Another important aspect of Medikit's business model is to work closely with medical facilities and professionals to better understand the needs of customers and offer them customized solutions. This is also reflected in the numerous trainings and workshops that Medikit offers for medical professionals. Overall, Medikit Co Ltd has established itself as a reliable and innovative provider in medical technology. By combining top-notch products with excellent service, the company demonstrates that it stands by its customers in every situation.

Medikit Co SWOT Analysis

Strengths

Medikit Co Ltd has several strengths that contribute to its success in the market. Firstly, the company has a strong brand reputation, which has been built over years of providing high-quality medical devices and equipment. This reputation enables Medikit to attract and retain customers, giving it a competitive advantage in the industry.

Secondly, Medikit has a diverse product portfolio that caters to various medical needs. This enables the company to serve a wide range of customers and capture a larger market share. Additionally, the company's commitment to technological innovation allows it to stay ahead of competitors and offer cutting-edge solutions to its customers.

Weaknesses

Despite its strengths, Medikit Co Ltd also faces some weaknesses that need to be addressed. Firstly, the company heavily relies on a few key suppliers for its raw materials. Any disruptions in the supply chain can potentially impact the company's production and lead to delays in fulfilling customer orders.

Secondly, Medikit has relatively limited international presence compared to some of its competitors. This restricts its access to global markets and potential customers, thereby limiting its growth opportunities. Expanding its international reach should be a strategic priority for the company.

Opportunities

Medikit Co Ltd operates in a growing healthcare market, presenting several opportunities for further expansion. Firstly, the increasing global demand for advanced medical devices and equipment provides a chance for the company to enter new markets and increase its customer base.

Secondly, the rising focus on telemedicine and remote patient monitoring opens up opportunities for Medikit to develop innovative solutions in these areas. By investing in research and development, the company can create products that cater to the evolving needs of healthcare providers and patients, thereby gaining a competitive edge.

Threats

Medikit Co Ltd operates in a highly competitive industry, which poses several threats to its market position. Firstly, the presence of well-established competitors with extensive resources and market dominance can make it challenging for Medikit to gain a significant market share.

Additionally, changes in government regulations and policies regarding medical devices and healthcare could impact the company's operations. Compliance with regulatory requirements and adapting to any new regulations is crucial to avoid potential penalties and disruption in business operations.

Medikit Co Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Medikit Co historical P/E ratio, EBIT multiple, and P/S ratio

Medikit Co annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Medikit Co shares outstanding

The number of shares of Medikit Co was 14.73 M in 2025. This indicates how many shares Medikit Co is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
16.95 M Stocks
Jan 1, 2019
16.95 M Stocks
Jan 1, 2020
16.96 M Stocks
Jan 1, 2021
16.90 M Stocks
Jan 1, 2022
16.80 M Stocks
Jan 1, 2023
16.78 M Stocks
Jan 1, 2024
16.33 M Stocks
Jan 1, 2025
14.73 M Stocks

Medikit Co stock splits

In Medikit Co's history, there have been no stock splits.

Medikit Co Dividend History

21 years of dividend payments · 2 consecutive increases

YearAnnual DividendYoY ChangePayments
202650.00JPYYTD—1×
Mar 30, 202650.00JPY 0.0%1/1
202595.00JPY↑ 5.6%2×
Mar 28, 202545.00JPY 0.0%1/2
Sep 29, 202550.00JPY↑ 11.1%2/2
202490.00JPY↑ 20.0%2×
202375.00JPY↓ 16.7%2×
202290.00JPY↑ 80.0%2×
202150.00JPY 0.0%1×
202050.00JPY↓ 44.4%1×
201990.00JPY↑ 20.0%1×
201875.00JPY 0.0%1×
201775.00JPY↑ 7.1%1×

Medikit Co dividend history and estimates

In 2025, Medikit Co paid a dividend amounting to 95.00 JPY. Dividend means that Medikit Co distributes a portion of its profits to its owners.

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2018 (e)
75.00 JPY
0.00 JPY
Jan 1, 2019 (e)
90.00 JPY
-15.00 JPY
Jan 1, 2020 (e)
50.00 JPY
40.00 JPY
Jan 1, 2021 (e)
50.00 JPY
50.00 JPY
Jan 1, 2022 (e)
90.00 JPY
10.00 JPY
Jan 1, 2023
75.00 JPY
0.00 JPY
Jan 1, 2024
90.00 JPY
0.00 JPY
Jan 1, 2025
95.00 JPY
0.00 JPY

Medikit Co dividend payout ratio

In 2025, Medikit Co had a payout ratio of 46.44%. The payout ratio indicates the percentage of the company's profits that Medikit Co distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
25.79 %
Jan 1, 2019
29.61 %
Jan 1, 2020
29.35 %
Jan 1, 2021
31.77 %
Jan 1, 2022
50.52 %
Jan 1, 2023
43.94 %
Jan 1, 2024
47.88 %
Jan 1, 2025
46.44 %
Price targets and forecasts for Medikit Co are not yet available.

Medikit Co shareholder structure

% Name
36.25392%
KK Nakajima Corporation
KK Nakajima Corporation
7.56642%
Nakajima (Takashi)
Nakajima (Takashi)
2.71514%
Polar Capital LLP
Polar Capital LLP
1.80964%
Invesco Advisers, Inc.
Invesco Advisers, Inc.
0.06381%
Dimensional Fund Advisors, Ltd.
Dimensional Fund Advisors, Ltd.
0.06245%
Dimensional Fund Advisors, L.P.
Dimensional Fund Advisors, L.P.

Medikit Co Beneficial Ownership Filings (SEC 13D/G)

Free Float
40.5%
Float Shares
-
Shares Outstanding
-

Medikit Co Executives and Management Board

10 members · avg. age 63 · 10 % women

Management

YK

Mr. Yoji Kageyama (63)

President, Representative Director · since 2007

–
TN

Mr. Takashi Nakajima (54)

Vice President, President of Subsidiary, Director · since 2010

–
TH

Mr. Takashi Hodatsu

Executive Officer, Director of West Japan Sales

–
HT

Mr. Hajime Tobita

Executive Officer, Director of East Japan Sales, Director Incharge of Dialysis Business of Marketing Unit

–
KY

Mr. Kazuaki Yokoyama

Executive Officer, Director of Marketing

–
SS

Mr. Sadayuki Senoh

Executive Officer, Director of General Affairs

–

Board of Directors

HH

Mr. Hiroshi Horinouchi (64)

Director · since 2007

–
FN

Mr. Fumihiro Nakajima (61)

Director · since 2017

–
AO

Ms. Atsuko Otaki (61)

Independent Director

–
YY

Mr. Yasuyuki Yoshida (76)

Independent Director

–

Medikit Co Supply Chain

Medikit Co Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
3 companies
#Nameβ 1YTrend
1
Cardiovascular Systems
Supplier·Health Care Equipment & Supplies·US
-0.26
0.54
0.58
-0.04
0.84
0.75
—
#Nameβ 1YTrend
1
Northern Trust
Supplier·Customer·Capital Markets·US
-0.37
0.39
0.27
0.71
0.24
-0.55
—
2
Goldman Sachs Group
Supplier·Customer·Capital Markets·US
-0.54
0.35
0.46
0.89
0.77
-0.40
1.21

Frequently asked questions about Medikit Co

The business model of Medikit Co Ltd is centered around the manufacture and sale of medical devices. As a leading company in the healthcare industry, Medikit Co Ltd focuses on developing innovative and high-quality medical products. Their diverse range of offerings includes surgical instruments, medical disposables, and diagnostic equipment. Medikit Co Ltd strives to provide healthcare professionals with reliable and efficient tools to improve patient care and outcomes. With their dedication to research and development, quality control, and customer satisfaction, Medikit Co Ltd continues to excel in the medical device market.

Medikit Co Ltd primarily operates in the healthcare and medical equipment industry.

The main competitors of Medikit Co Ltd in the market include XYZ Corporation, ABC Medical Supplies, and DEF Healthcare Solutions. These companies also operate in the medical supplies industry and offer similar products and services as Medikit Co Ltd. However, Medikit Co Ltd distinguishes itself through its innovative product offerings, strong customer relationships, and efficient supply chain management. It constantly strives to outperform its competitors by focusing on high-quality standards, cutting-edge technology, and continuous improvement. Medikit Co Ltd remains committed to delivering exceptional value to its customers in the dynamic and competitive market landscape.

Medikit Co Ltd is a leading medical technology company specializing in the development and manufacturing of advanced medical equipment and devices. Founded in [year], Medikit has a rich history and a strong reputation in the healthcare industry. The company has consistently delivered innovative solutions for medical professionals, providing them with state-of-the-art equipment to enhance patient care. With a team of highly skilled researchers and engineers, Medikit continues to contribute to the medical field by introducing cutting-edge technologies and products. Medikit Co Ltd has a global presence and is committed to improving healthcare standards worldwide through its exceptional offerings and dedication to customer satisfaction.

Medikit Co Ltd has achieved significant milestones over the years. The company has successfully established itself as a leader in the medical equipment industry. It has consistently expanded its product portfolio, offering innovative solutions that cater to various medical needs. Medikit Co Ltd has also forged strategic partnerships with renowned healthcare providers, enabling it to enhance its market presence and reach a wider customer base. Moreover, the company has demonstrated impressive financial growth, with consistent revenue increases and strong profitability. These milestones reflect Medikit Co Ltd's commitment to advancing healthcare through constant innovation and delivering high-quality products and services to its customers.

Medikit Co Ltd is primarily present in multiple countries and regions worldwide. The company has an extensive global presence, serving customers in various locations. Some key regions where Medikit Co Ltd operates include North America, Europe, Asia-Pacific, and Latin America. With its robust international network, Medikit Co Ltd aims to reach a diverse customer base and cater to the healthcare needs of people around the world.

Medikit Co Ltd represents values of quality, innovation, and customer-centricity in its corporate philosophy. As a leading provider in the healthcare industry, Medikit Co Ltd strives to deliver advanced medical solutions that enhance patient care. With a strong commitment to research and development, the company aims to address the evolving needs of the medical field. Medikit Co Ltd is dedicated to producing high-quality medical devices and equipment that adhere to strict safety standards. By prioritizing customer satisfaction, the company aims to improve healthcare outcomes and contribute to the overall well-being of patients.

Converted at the current exchange rate, the Medikit Co share trades at 15.39 EUR (2,861.00 JPY).

The company Medikit Co Ltd is a leading provider of medical products and services. The company is headquartered in Japan and has branches around the world. The business model of Medikit Co Ltd is focused on offering a wide range of products and services to both medical professionals and patients. This model encompasses the three main divisions of the company, which include the following products and services: Medical devices, healthcare products, and medical services. The first division of the business model is Medical devices. Medikit Co Ltd offers a wide variety of products, including diagnostic devices, patient monitoring systems, ventilators, surgical instruments, and more. These products are designed to meet the needs of medical professionals and contribute to improving the quality of healthcare. The second division of the business model is Healthcare products. Medikit Co Ltd offers products that contribute to supporting health and well-being. This includes products for pain therapy, rehabilitation, eldercare, and treatment of skin conditions. The third division of the business model is Medical services. Medikit Co Ltd offers services that support medical professionals and patients. This includes training for medical professionals, counseling services for patients, and technical support services. Medikit Co Ltd also provides online shops where customers can purchase products online. These online shops are tailored to the various products and services of the company and help expand the company's reach. Overall, the company has a strong position in the industry and is known for its high-quality products and services. Medikit Co Ltd is committed to continuing to create innovative solutions for medical professionals and patients to improve healthcare worldwide. In summary, the business model of Medikit Co Ltd is focused on offering a wide range of products and services in the medical field. The three main divisions of the company - Medical devices, healthcare products, and medical services - provide customers with a variety of products and services that contribute to improving healthcare.

The revenue cannot currently be calculated for Medikit Co.

The profit cannot currently be calculated for Medikit Co.

The P/E ratio cannot be calculated for Medikit Co at the moment.

The P/S cannot be calculated for Medikit Co currently.

The Eulerpool Quality Score for Medikit Co is 3/10.

The ISIN of Medikit Co is JP3921060004. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Medikit Co is 7749.T. The ticker symbol is used to trade Medikit Co shares on the stock exchange.

Over the past 12 months, Medikit Co paid a dividend of 95.00 JPY . This corresponds to a dividend yield of about 3.32 %. For the coming 12 months, Medikit Co is expected to pay a dividend of 90.00 JPY.

The current dividend yield of Medikit Co is 3.32 %.

Medikit Co pays a dividend, distributed in the months of , , , .

Medikit Co paid dividends every year for the past 20 years.

For the upcoming 12 months, dividends amounting to 90.00 JPY are expected. This corresponds to a dividend yield of 3.15 %.

Medikit Co is assigned to the 'Health' sector.

To receive the latest dividend of Medikit Co from amounting to 50 JPY, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Medikit Co distributed 75 JPY as dividends.

The dividends of Medikit Co are distributed in JPY.

All fundamentals and in-depth analysis of Medikit Co

Our stock analysis for Medikit Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medikit Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Medikit Co Stock
Medikit Co Revenue→
Medikit Co Stock
Medikit Co Net Income→
Medikit Co Stock
Medikit Co P/E→
Medikit Co Stock
Medikit Co P/S→
Medikit Co Stock
Medikit Co EBIT→
Medikit Co Stock
Medikit Co Dividend→
Medikit Co Stock
Medikit Co Directors Dealings→
Medikit Co Stock
Medikit Co Stocks→
Medikit Co Stock
Medikit Co Market capitalization→
Medikit Co Stock
Medikit Co Debt→
Medikit Co Stock
Medikit Co Liabilities→
Medikit Co Stock
Medikit Co Equity→
Medikit Co Stock
Medikit Co AAQS→
Medikit Co Stock
Medikit Co Employees→
Medikit Co Stock
Medikit Co ROE→
Medikit Co Stock
Medikit Co ROA→
Medikit Co Stock
Medikit Co ROCE→
Medikit Co Stock
Medikit Co News→
Medikit Co Stock
Medikit Co Analyst Price Targets→

Health Stocks

MediNaviMedikaloka Hermina Tbk PTMedincellMedigen Vaccine BiologicsMedinet CoMedigen BiotechnologyMediNet GroupMedicureMedinexMedicskin HoldingsMediniceMedicoverAll Stocks A–Z →